Development of an individualized dementia risk prediction model using deep learning survival analysis incorporating genetic and environmental factors

Dementia is a major public health challenge in modern society. Early detection of high-risk dementia patients and timely intervention or treatment are of significant clinical importance. Neural network survival analysis represents the most advanced technology for survival analysis to date. However,...

Full description

Saved in:
Bibliographic Details
Published inAlzheimer's research & therapy Vol. 16; no. 1; pp. 278 - 17
Main Authors Yuan, Shiqi, Liu, Qing, Huang, Xiaxuan, Tan, Shanyuan, Bai, Zihong, Yu, Juan, Lei, Fazhen, Le, Huan, Ye, Qingqing, Peng, Xiaoxue, Yang, Juying, Ling, Yitong, Lyu, Jun
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 30.12.2024
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Dementia is a major public health challenge in modern society. Early detection of high-risk dementia patients and timely intervention or treatment are of significant clinical importance. Neural network survival analysis represents the most advanced technology for survival analysis to date. However, there is a lack of deep learning-based survival analysis models that integrate both genetic and clinical factors to develop and validate individualized dynamic dementia risk prediction models. This study is based on a large prospective cohort from the UK Biobank, which includes a total of 41,484 participants with an average follow-up period of 12.6 years. Initially, 364 candidate features (predictor variables) were screened. The top 30 key features were then identified by ranking the importance of each predictor variable using the Gradient Boosting Machine (GBM) model. A multi-model comparison strategy was employed to evaluate the predictive performance of four survival analysis models: DeepSurv, DeepHit, Kaplan-Meier estimation, and the Cox proportional hazards model (CoxPH). The results showed that the average Harrell's C-index for the DeepSurv model was 0.743, for the DeepHit model it was 0.633, for the CoxPH model it was 0.749, and for the Kaplan-Meier estimator model it was 0.500. In addition, the average D-Calibration Survival Measure was 6.014, 4408.086, 32274.743, and 1.508, respectively. The Brier score (BS) was used to assess the importance of features for the DeepSurv dementia prediction model, and the relationship between features and dementia was visualized using a partial dependence plot (PDP). To facilitate further research, the team deployed the DeepSurv dementia prediction model on AliCloud servers and designated it as the UKB-DementiaPre Tool. This study successfully developed and validated the DeepSurv dementia prediction model for individuals aged 60 years and above, integrating both genetic and clinical data. The model was then deployed on AliCloud servers to promote its clinical translation. It is anticipated that this prediction model will provide more accurate decision support for clinical treatment and will serve as a valuable tool for the primary prevention of dementia.
AbstractList Background Dementia is a major public health challenge in modern society. Early detection of high-risk dementia patients and timely intervention or treatment are of significant clinical importance. Neural network survival analysis represents the most advanced technology for survival analysis to date. However, there is a lack of deep learning-based survival analysis models that integrate both genetic and clinical factors to develop and validate individualized dynamic dementia risk prediction models. Methods and results This study is based on a large prospective cohort from the UK Biobank, which includes a total of 41,484 participants with an average follow-up period of 12.6 years. Initially, 364 candidate features (predictor variables) were screened. The top 30 key features were then identified by ranking the importance of each predictor variable using the Gradient Boosting Machine (GBM) model. A multi-model comparison strategy was employed to evaluate the predictive performance of four survival analysis models: DeepSurv, DeepHit, Kaplan-Meier estimation, and the Cox proportional hazards model (CoxPH). The results showed that the average Harrell's C-index for the DeepSurv model was 0.743, for the DeepHit model it was 0.633, for the CoxPH model it was 0.749, and for the Kaplan-Meier estimator model it was 0.500. In addition, the average D-Calibration Survival Measure was 6.014, 4408.086, 32274.743, and 1.508, respectively. The Brier score (BS) was used to assess the importance of features for the DeepSurv dementia prediction model, and the relationship between features and dementia was visualized using a partial dependence plot (PDP). To facilitate further research, the team deployed the DeepSurv dementia prediction model on AliCloud servers and designated it as the UKB-DementiaPre Tool. Conclusion This study successfully developed and validated the DeepSurv dementia prediction model for individuals aged 60 years and above, integrating both genetic and clinical data. The model was then deployed on AliCloud servers to promote its clinical translation. It is anticipated that this prediction model will provide more accurate decision support for clinical treatment and will serve as a valuable tool for the primary prevention of dementia. Keywords: Dementia, DeepSurv, Risk prediction model, Survival analysis
Dementia is a major public health challenge in modern society. Early detection of high-risk dementia patients and timely intervention or treatment are of significant clinical importance. Neural network survival analysis represents the most advanced technology for survival analysis to date. However, there is a lack of deep learning-based survival analysis models that integrate both genetic and clinical factors to develop and validate individualized dynamic dementia risk prediction models. This study is based on a large prospective cohort from the UK Biobank, which includes a total of 41,484 participants with an average follow-up period of 12.6 years. Initially, 364 candidate features (predictor variables) were screened. The top 30 key features were then identified by ranking the importance of each predictor variable using the Gradient Boosting Machine (GBM) model. A multi-model comparison strategy was employed to evaluate the predictive performance of four survival analysis models: DeepSurv, DeepHit, Kaplan-Meier estimation, and the Cox proportional hazards model (CoxPH). The results showed that the average Harrell's C-index for the DeepSurv model was 0.743, for the DeepHit model it was 0.633, for the CoxPH model it was 0.749, and for the Kaplan-Meier estimator model it was 0.500. In addition, the average D-Calibration Survival Measure was 6.014, 4408.086, 32274.743, and 1.508, respectively. The Brier score (BS) was used to assess the importance of features for the DeepSurv dementia prediction model, and the relationship between features and dementia was visualized using a partial dependence plot (PDP). To facilitate further research, the team deployed the DeepSurv dementia prediction model on AliCloud servers and designated it as the UKB-DementiaPre Tool. This study successfully developed and validated the DeepSurv dementia prediction model for individuals aged 60 years and above, integrating both genetic and clinical data. The model was then deployed on AliCloud servers to promote its clinical translation. It is anticipated that this prediction model will provide more accurate decision support for clinical treatment and will serve as a valuable tool for the primary prevention of dementia.
Dementia is a major public health challenge in modern society. Early detection of high-risk dementia patients and timely intervention or treatment are of significant clinical importance. Neural network survival analysis represents the most advanced technology for survival analysis to date. However, there is a lack of deep learning-based survival analysis models that integrate both genetic and clinical factors to develop and validate individualized dynamic dementia risk prediction models.BACKGROUNDDementia is a major public health challenge in modern society. Early detection of high-risk dementia patients and timely intervention or treatment are of significant clinical importance. Neural network survival analysis represents the most advanced technology for survival analysis to date. However, there is a lack of deep learning-based survival analysis models that integrate both genetic and clinical factors to develop and validate individualized dynamic dementia risk prediction models.This study is based on a large prospective cohort from the UK Biobank, which includes a total of 41,484 participants with an average follow-up period of 12.6 years. Initially, 364 candidate features (predictor variables) were screened. The top 30 key features were then identified by ranking the importance of each predictor variable using the Gradient Boosting Machine (GBM) model. A multi-model comparison strategy was employed to evaluate the predictive performance of four survival analysis models: DeepSurv, DeepHit, Kaplan-Meier estimation, and the Cox proportional hazards model (CoxPH). The results showed that the average Harrell's C-index for the DeepSurv model was 0.743, for the DeepHit model it was 0.633, for the CoxPH model it was 0.749, and for the Kaplan-Meier estimator model it was 0.500. In addition, the average D-Calibration Survival Measure was 6.014, 4408.086, 32274.743, and 1.508, respectively. The Brier score (BS) was used to assess the importance of features for the DeepSurv dementia prediction model, and the relationship between features and dementia was visualized using a partial dependence plot (PDP). To facilitate further research, the team deployed the DeepSurv dementia prediction model on AliCloud servers and designated it as the UKB-DementiaPre Tool.METHODS AND RESULTSThis study is based on a large prospective cohort from the UK Biobank, which includes a total of 41,484 participants with an average follow-up period of 12.6 years. Initially, 364 candidate features (predictor variables) were screened. The top 30 key features were then identified by ranking the importance of each predictor variable using the Gradient Boosting Machine (GBM) model. A multi-model comparison strategy was employed to evaluate the predictive performance of four survival analysis models: DeepSurv, DeepHit, Kaplan-Meier estimation, and the Cox proportional hazards model (CoxPH). The results showed that the average Harrell's C-index for the DeepSurv model was 0.743, for the DeepHit model it was 0.633, for the CoxPH model it was 0.749, and for the Kaplan-Meier estimator model it was 0.500. In addition, the average D-Calibration Survival Measure was 6.014, 4408.086, 32274.743, and 1.508, respectively. The Brier score (BS) was used to assess the importance of features for the DeepSurv dementia prediction model, and the relationship between features and dementia was visualized using a partial dependence plot (PDP). To facilitate further research, the team deployed the DeepSurv dementia prediction model on AliCloud servers and designated it as the UKB-DementiaPre Tool.This study successfully developed and validated the DeepSurv dementia prediction model for individuals aged 60 years and above, integrating both genetic and clinical data. The model was then deployed on AliCloud servers to promote its clinical translation. It is anticipated that this prediction model will provide more accurate decision support for clinical treatment and will serve as a valuable tool for the primary prevention of dementia.CONCLUSIONThis study successfully developed and validated the DeepSurv dementia prediction model for individuals aged 60 years and above, integrating both genetic and clinical data. The model was then deployed on AliCloud servers to promote its clinical translation. It is anticipated that this prediction model will provide more accurate decision support for clinical treatment and will serve as a valuable tool for the primary prevention of dementia.
Dementia is a major public health challenge in modern society. Early detection of high-risk dementia patients and timely intervention or treatment are of significant clinical importance. Neural network survival analysis represents the most advanced technology for survival analysis to date. However, there is a lack of deep learning-based survival analysis models that integrate both genetic and clinical factors to develop and validate individualized dynamic dementia risk prediction models. This study is based on a large prospective cohort from the UK Biobank, which includes a total of 41,484 participants with an average follow-up period of 12.6 years. Initially, 364 candidate features (predictor variables) were screened. The top 30 key features were then identified by ranking the importance of each predictor variable using the Gradient Boosting Machine (GBM) model. A multi-model comparison strategy was employed to evaluate the predictive performance of four survival analysis models: DeepSurv, DeepHit, Kaplan-Meier estimation, and the Cox proportional hazards model (CoxPH). The results showed that the average Harrell's C-index for the DeepSurv model was 0.743, for the DeepHit model it was 0.633, for the CoxPH model it was 0.749, and for the Kaplan-Meier estimator model it was 0.500. In addition, the average D-Calibration Survival Measure was 6.014, 4408.086, 32274.743, and 1.508, respectively. The Brier score (BS) was used to assess the importance of features for the DeepSurv dementia prediction model, and the relationship between features and dementia was visualized using a partial dependence plot (PDP). To facilitate further research, the team deployed the DeepSurv dementia prediction model on AliCloud servers and designated it as the UKB-DementiaPre Tool. This study successfully developed and validated the DeepSurv dementia prediction model for individuals aged 60 years and above, integrating both genetic and clinical data. The model was then deployed on AliCloud servers to promote its clinical translation. It is anticipated that this prediction model will provide more accurate decision support for clinical treatment and will serve as a valuable tool for the primary prevention of dementia.
Abstract Background Dementia is a major public health challenge in modern society. Early detection of high-risk dementia patients and timely intervention or treatment are of significant clinical importance. Neural network survival analysis represents the most advanced technology for survival analysis to date. However, there is a lack of deep learning-based survival analysis models that integrate both genetic and clinical factors to develop and validate individualized dynamic dementia risk prediction models. Methods and results This study is based on a large prospective cohort from the UK Biobank, which includes a total of 41,484 participants with an average follow-up period of 12.6 years. Initially, 364 candidate features (predictor variables) were screened. The top 30 key features were then identified by ranking the importance of each predictor variable using the Gradient Boosting Machine (GBM) model. A multi-model comparison strategy was employed to evaluate the predictive performance of four survival analysis models: DeepSurv, DeepHit, Kaplan–Meier estimation, and the Cox proportional hazards model (CoxPH). The results showed that the average Harrell's C-index for the DeepSurv model was 0.743, for the DeepHit model it was 0.633, for the CoxPH model it was 0.749, and for the Kaplan–Meier estimator model it was 0.500. In addition, the average D-Calibration Survival Measure was 6.014, 4408.086, 32274.743, and 1.508, respectively. The Brier score (BS) was used to assess the importance of features for the DeepSurv dementia prediction model, and the relationship between features and dementia was visualized using a partial dependence plot (PDP). To facilitate further research, the team deployed the DeepSurv dementia prediction model on AliCloud servers and designated it as the UKB-DementiaPre Tool. Conclusion This study successfully developed and validated the DeepSurv dementia prediction model for individuals aged 60 years and above, integrating both genetic and clinical data. The model was then deployed on AliCloud servers to promote its clinical translation. It is anticipated that this prediction model will provide more accurate decision support for clinical treatment and will serve as a valuable tool for the primary prevention of dementia.
ArticleNumber 278
Audience Academic
Author Yang, Juying
Lyu, Jun
Bai, Zihong
Le, Huan
Ye, Qingqing
Ling, Yitong
Huang, Xiaxuan
Yu, Juan
Tan, Shanyuan
Lei, Fazhen
Liu, Qing
Peng, Xiaoxue
Yuan, Shiqi
Author_xml – sequence: 1
  givenname: Shiqi
  surname: Yuan
  fullname: Yuan, Shiqi
– sequence: 2
  givenname: Qing
  surname: Liu
  fullname: Liu, Qing
– sequence: 3
  givenname: Xiaxuan
  surname: Huang
  fullname: Huang, Xiaxuan
– sequence: 4
  givenname: Shanyuan
  surname: Tan
  fullname: Tan, Shanyuan
– sequence: 5
  givenname: Zihong
  surname: Bai
  fullname: Bai, Zihong
– sequence: 6
  givenname: Juan
  surname: Yu
  fullname: Yu, Juan
– sequence: 7
  givenname: Fazhen
  surname: Lei
  fullname: Lei, Fazhen
– sequence: 8
  givenname: Huan
  surname: Le
  fullname: Le, Huan
– sequence: 9
  givenname: Qingqing
  surname: Ye
  fullname: Ye, Qingqing
– sequence: 10
  givenname: Xiaoxue
  surname: Peng
  fullname: Peng, Xiaoxue
– sequence: 11
  givenname: Juying
  surname: Yang
  fullname: Yang, Juying
– sequence: 12
  givenname: Yitong
  surname: Ling
  fullname: Ling, Yitong
– sequence: 13
  givenname: Jun
  surname: Lyu
  fullname: Lyu, Jun
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39736679$$D View this record in MEDLINE/PubMed
BookMark eNptkk1r3DAQhk1JaZJt_0APxVAIvTi1JFuWTyWkX4FAL-1ZjKXxrlKt5Eq2Q_o_8n8jZ9OwC0UHfcwzrzSa9zQ7ct5hlr0l5Tkhgn-MhJG2LkpaFSXhnBW3L7IT0tSiaEnLjvbWx9lpjDdlyTkV1avsmLUN47xpT7L7zzij9cMW3Zj7PgeXG6fNbPQE1vxFnWtcYgbyYOLvfAiojRqNd_nWa7T5FI1bJwiH3CIEt-ziFGYzg01qYO-iiUlT-TD4AOMSX6PD0agU1jm62QTvljtSQg9q9CG-zl72YCO-eZpX2a-vX35efi-uf3y7ury4LlRNxFj0VFBVdYR3PXQk7VrBuUKEWre8I7oFwJojUZS1AgWrFAOkRKhGkJ5rYKvsaqerPdzIIZgthDvpwcjHAx_WEkJ6qUWpG94AUVq0jFYa644giIbSkgreNxVNWp92WsPUbVGrVFAAeyB6GHFmI9d-loRwURFaJYUPTwrB_5kwjnJrokJrwaGfomSkLllVUcIS-n6HriG9zbjeJ0m14PJCpArTT6S2r7Lz_1BppJ4alczUm3R-kHC2l7BBsOMmejst_Y6H4Lv9Yp-r_GesBNAdoIKPMWD_jJBSLu6VO_fK5F756F55yx4AAiHloQ
Cites_doi 10.1371/journal.pmed.1001779
10.1371/journal.pone.0211957
10.1371/journal.pone.0251365
10.3390/bs13090737
10.1001/jamainternmed.2016.6807
10.1093/hmg/ddz187
10.3389/fpsyg.2024.1410396
10.1038/s41598-023-27892-x
10.3390/bioengineering10020245
10.1186/s12890-024-02945-7
10.1016/S1474-4422(15)00092-7
10.1093/cvr/cvz294
10.1093/ageing/afx044
10.1186/s12916-016-0549-y
10.1186/s12874-018-0482-1
10.1186/s12859-020-03850-6
10.1136/bmjopen-2015-008048
10.1161/CIRCRESAHA.122.319951
10.1038/s41582-022-00698-7
10.3390/s23187712
10.1038/s41598-020-60444-1
10.1007/s11892-014-0487-z
10.1177/2040622321992624
10.2337/dc15-1588
10.3389/fpls.2021.749854
10.3390/diagnostics13193159
10.1186/s12916-020-01578-x
10.1177/002076409504100105
10.1002/ana.25910
10.3390/s19214671
10.5114/aoms/156477
10.3389/fnagi.2023.1200671
10.3390/s21217424
10.1016/j.ajcnut.2023.01.015
10.1038/s41398-018-0150-6
10.3390/s23031279
10.3390/genes11080888
10.1093/nar/gkac830
10.1007/s40336-022-00487-8
10.1111/pcn.13561
10.2196/12910
10.1001/jama.1982.03320430047030
10.3389/fpubh.2023.1100960
10.1016/j.jagp.2015.12.005
10.1093/eurheartj/ehz849
10.1016/B978-012369440-9/50024-4
10.1038/s41588-018-0311-9
10.1212/WNL.47.1.254
10.1001/archneur.64.12.1743
10.1038/s41598-024-64296-x
10.1016/j.toxrep.2024.101756
10.1097/YCO.0000000000000768
10.1186/s13195-022-01140-2
10.1016/S2589-7500(21)00249-1
10.1186/s12883-021-02276-8
ContentType Journal Article
Copyright 2024. The Author(s).
COPYRIGHT 2024 BioMed Central Ltd.
The Author(s) 2024 2024
Copyright_xml – notice: 2024. The Author(s).
– notice: COPYRIGHT 2024 BioMed Central Ltd.
– notice: The Author(s) 2024 2024
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1186/s13195-024-01663-w
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList


MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 1758-9193
EndPage 17
ExternalDocumentID oai_doaj_org_article_d767a1cd89324de5b1ea87220286f742
PMC11684124
A821889819
39736679
10_1186_s13195_024_01663_w
Genre Journal Article
GeographicLocations United Kingdom
China
GeographicLocations_xml – name: United Kingdom
– name: China
GrantInformation_xml – fundername: Guangdong Provincial Key Laboratory of Traditional Chinese Medicine Informatization
  grantid: 2021B1212040007
– fundername: Special Projects for Scientific and Technological Research in Chinese Medicine and Ethnomedicine
  grantid: QZYY-2024-035
GroupedDBID ---
0R~
23M
2WC
53G
5VS
6J9
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFS
ACIHN
ACJQM
ACUHS
ADBBV
ADUKV
AEAQA
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIAM
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
DIK
E3Z
EBD
EBLON
EBS
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HZ~
IAO
IEA
IHR
IHW
INH
INR
ITC
KQ8
M1P
M~E
O5R
O5S
O9-
OK1
P2P
P6G
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
ROL
RPM
RSV
SBL
SOJ
TR2
TUS
UKHRP
-56
-5G
-BR
3V.
ACRMQ
ADINQ
C24
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7X8
PJZUB
PPXIY
5PM
PUEGO
ID FETCH-LOGICAL-c518t-f282c4b16bfab1f289866ceea5d96b1d9aae56e1c2398e834c3ae218c781f6da3
IEDL.DBID DOA
ISSN 1758-9193
IngestDate Wed Aug 27 01:28:03 EDT 2025
Thu Aug 21 18:34:47 EDT 2025
Tue Aug 05 11:11:53 EDT 2025
Tue Jun 17 21:58:19 EDT 2025
Tue Jun 10 20:58:40 EDT 2025
Thu May 22 21:23:36 EDT 2025
Sun Jan 05 01:57:30 EST 2025
Tue Jul 01 02:38:56 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Risk prediction model
Survival analysis
DeepSurv
Dementia
Language English
License 2024. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c518t-f282c4b16bfab1f289866ceea5d96b1d9aae56e1c2398e834c3ae218c781f6da3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doaj.org/article/d767a1cd89324de5b1ea87220286f742
PMID 39736679
PQID 3150344213
PQPubID 23479
PageCount 17
ParticipantIDs doaj_primary_oai_doaj_org_article_d767a1cd89324de5b1ea87220286f742
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11684124
proquest_miscellaneous_3150344213
gale_infotracmisc_A821889819
gale_infotracacademiconefile_A821889819
gale_healthsolutions_A821889819
pubmed_primary_39736679
crossref_primary_10_1186_s13195_024_01663_w
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-12-30
PublicationDateYYYYMMDD 2024-12-30
PublicationDate_xml – month: 12
  year: 2024
  text: 2024-12-30
  day: 30
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Alzheimer's research & therapy
PublicationTitleAlternate Alzheimers Res Ther
PublicationYear 2024
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References 1663_CR32
SD Edland (1663_CR52) 1996; 47
TP Nguyen (1663_CR30) 2022; 2022
NS Rost (1663_CR59) 2022; 130
LE Trigg (1663_CR35) 2023; 13
HY Sayed (1663_CR40) 2024; 13
H Chen (1663_CR51) 2023; 117
W Li (1663_CR11) 2023; 19
A Sharma (1663_CR20) 2021; 16
H Haider (1663_CR34) 2020; 21
A Rozet (1663_CR27) 2019; 21
Y Lin (1663_CR47) 2020; 11
RE Marioni (1663_CR16) 2018; 8
C Sudlow (1663_CR14) 2015; 12
X Heng (1663_CR2) 2023; 11
P Sanga (1663_CR28) 2023; 13
IA Kang (1663_CR25) 2023; 10
S Tsuzuki (1663_CR36) 2020; 10
DJ Oh (1663_CR54) 2023; 77
KM Park (1663_CR8) 2019; 14
T Ninomiya (1663_CR57) 2014; 14
G Kaur (1663_CR45) 2022; 10
C Prasanna (1663_CR23) 2023; 23
W Xu (1663_CR49) 2015; 86
X Shang (1663_CR55) 2023; 15
1663_CR41
TG Fong (1663_CR1) 2022; 18
Y Minami (1663_CR60) 1995; 41
A Merkin (1663_CR10) 2022; 35
Q Zhou (1663_CR37) 2021; 12
SJ Jiao (1663_CR31) 2021; 21
Z Raisi-Estabragh (1663_CR15) 2020; 116
IE Jansen (1663_CR17) 2019; 51
Y Liu (1663_CR26) 2024; 14
JB Chen (1663_CR44) 2021; 12
SA Lambert (1663_CR50) 2019; 28
J Steinfeldt (1663_CR13) 2022; 4
FJ Harrell (1663_CR33) 1982; 247
M Salwa (1663_CR38) 2024; 8
W Yang (1663_CR29) 2019; 19
C Surianarayanan (1663_CR46) 2023; 23
KM Langa (1663_CR4) 2017; 177
JL Katzman (1663_CR12) 2018; 18
L Wang (1663_CR9) 2021; 21
E Gomez-Tortosa (1663_CR53) 2007; 64
JJ Zhang (1663_CR56) 2023; 15
1663_CR21
NA Kochan (1663_CR62) 2016; 24
YT Wu (1663_CR5) 2016; 15
Y Leng (1663_CR18) 2021; 89
C Cooper (1663_CR61) 2017; 46
X Zou (1663_CR39) 2024; 24
J Feng (1663_CR43) 2021; 22
M Fan (1663_CR19) 2020; 41
K Walters (1663_CR7) 2016; 14
A Fayosse (1663_CR48) 2020; 18
S Chatterjee (1663_CR58) 2016; 39
A Bashiri (1663_CR42) 2017; 46
D Huang (1663_CR24) 2022; 50
M Tao (1663_CR6) 2023; 13
A Page (1663_CR3) 2015; 5
Q Wang (1663_CR22) 2024; 15
References_xml – volume: 12
  year: 2015
  ident: 1663_CR14
  publication-title: PLOS Med
  doi: 10.1371/journal.pmed.1001779
– volume: 14
  start-page: e0211957
  year: 2019
  ident: 1663_CR8
  publication-title: PLoS One.
  doi: 10.1371/journal.pone.0211957
– volume: 16
  start-page: e0251365
  year: 2021
  ident: 1663_CR20
  publication-title: PLoS One.
  doi: 10.1371/journal.pone.0251365
– volume: 13
  start-page: 737
  year: 2023
  ident: 1663_CR6
  publication-title: Behav Sci (Basel).
  doi: 10.3390/bs13090737
– volume: 177
  start-page: 51
  year: 2017
  ident: 1663_CR4
  publication-title: JAMA Intern Med
  doi: 10.1001/jamainternmed.2016.6807
– volume: 28
  start-page: R133
  year: 2019
  ident: 1663_CR50
  publication-title: HUM MOL GENET
  doi: 10.1093/hmg/ddz187
– volume: 15
  start-page: 1410396
  year: 2024
  ident: 1663_CR22
  publication-title: FRONT PSYCHOL
  doi: 10.3389/fpsyg.2024.1410396
– ident: 1663_CR32
– volume: 13
  start-page: 3063
  year: 2023
  ident: 1663_CR35
  publication-title: SCI REP-UK
  doi: 10.1038/s41598-023-27892-x
– volume: 10
  start-page: 245
  year: 2023
  ident: 1663_CR25
  publication-title: Bioengineering (Basel).
  doi: 10.3390/bioengineering10020245
– volume: 24
  start-page: 153
  year: 2024
  ident: 1663_CR39
  publication-title: BMC PULM MED
  doi: 10.1186/s12890-024-02945-7
– volume: 15
  start-page: 116
  year: 2016
  ident: 1663_CR5
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(15)00092-7
– volume: 116
  start-page: e12
  year: 2020
  ident: 1663_CR15
  publication-title: Cardiovasc Res
  doi: 10.1093/cvr/cvz294
– volume: 46
  start-page: 393
  year: 2017
  ident: 1663_CR61
  publication-title: AGE AGEING
  doi: 10.1093/ageing/afx044
– volume: 14
  start-page: 6
  year: 2016
  ident: 1663_CR7
  publication-title: BMC Med
  doi: 10.1186/s12916-016-0549-y
– volume: 18
  start-page: 24
  year: 2018
  ident: 1663_CR12
  publication-title: BMC Med Res Methodol
  doi: 10.1186/s12874-018-0482-1
– volume: 22
  start-page: 47
  year: 2021
  ident: 1663_CR43
  publication-title: BMC Bioinformatics
  doi: 10.1186/s12859-020-03850-6
– volume: 5
  start-page: e008048
  year: 2015
  ident: 1663_CR3
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2015-008048
– volume: 130
  start-page: 1252
  year: 2022
  ident: 1663_CR59
  publication-title: CIRC RES
  doi: 10.1161/CIRCRESAHA.122.319951
– volume: 18
  start-page: 579
  year: 2022
  ident: 1663_CR1
  publication-title: Nat Rev Neurol.
  doi: 10.1038/s41582-022-00698-7
– volume: 23
  start-page: 7712
  year: 2023
  ident: 1663_CR23
  publication-title: Sensors (Basel).
  doi: 10.3390/s23187712
– volume: 10
  start-page: 3502
  year: 2020
  ident: 1663_CR36
  publication-title: SCI REP-UK
  doi: 10.1038/s41598-020-60444-1
– volume: 14
  start-page: 487
  year: 2014
  ident: 1663_CR57
  publication-title: CURR DIABETES REP
  doi: 10.1007/s11892-014-0487-z
– volume: 12
  start-page: 1755284400
  year: 2021
  ident: 1663_CR44
  publication-title: THER ADV CHRONIC DIS
  doi: 10.1177/2040622321992624
– volume: 39
  start-page: 300
  year: 2016
  ident: 1663_CR58
  publication-title: Diabetes Care.
  doi: 10.2337/dc15-1588
– volume: 12
  start-page: 749854
  year: 2021
  ident: 1663_CR37
  publication-title: Front Plant Sci.
  doi: 10.3389/fpls.2021.749854
– volume: 21
  start-page: 1
  year: 2020
  ident: 1663_CR34
  publication-title: J Mach Learn Res.
– volume: 13
  start-page: 3159
  year: 2023
  ident: 1663_CR28
  publication-title: Diagnostics.
  doi: 10.3390/diagnostics13193159
– volume: 18
  start-page: 107
  year: 2020
  ident: 1663_CR48
  publication-title: BMC MED
  doi: 10.1186/s12916-020-01578-x
– volume: 46
  start-page: 165
  year: 2017
  ident: 1663_CR42
  publication-title: IRAN J PUBLIC HEALTH
– volume: 41
  start-page: 47
  year: 1995
  ident: 1663_CR60
  publication-title: INT J SOC PSYCHIATR
  doi: 10.1177/002076409504100105
– volume: 89
  start-page: 177
  year: 2021
  ident: 1663_CR18
  publication-title: ANN NEUROL
  doi: 10.1002/ana.25910
– volume: 19
  start-page: 4671
  year: 2019
  ident: 1663_CR29
  publication-title: Sensors (Basel).
  doi: 10.3390/s19214671
– volume: 19
  start-page: 264
  year: 2023
  ident: 1663_CR11
  publication-title: ARCH Med Sci
  doi: 10.5114/aoms/156477
– volume: 15
  start-page: 1200671
  year: 2023
  ident: 1663_CR56
  publication-title: FRONT AGING NEUROSCI
  doi: 10.3389/fnagi.2023.1200671
– volume: 21
  start-page: 7424
  year: 2021
  ident: 1663_CR31
  publication-title: Sensors (Basel).
  doi: 10.3390/s21217424
– volume: 117
  start-page: 672
  year: 2023
  ident: 1663_CR51
  publication-title: AM J CLIN NUTR
  doi: 10.1016/j.ajcnut.2023.01.015
– ident: 1663_CR21
– volume: 8
  start-page: 99
  year: 2018
  ident: 1663_CR16
  publication-title: Transl Psychiat
  doi: 10.1038/s41398-018-0150-6
– volume: 23
  start-page: 1279
  year: 2023
  ident: 1663_CR46
  publication-title: Sensors (Basel).
  doi: 10.3390/s23031279
– volume: 11
  start-page: 888
  year: 2020
  ident: 1663_CR47
  publication-title: Genes (Basel).
  doi: 10.3390/genes11080888
– volume: 50
  start-page: 10290
  year: 2022
  ident: 1663_CR24
  publication-title: NUCLEIC ACIDS RES
  doi: 10.1093/nar/gkac830
– volume: 10
  start-page: 355
  year: 2022
  ident: 1663_CR45
  publication-title: CLIN TRANSL IMAGING
  doi: 10.1007/s40336-022-00487-8
– volume: 77
  start-page: 449
  year: 2023
  ident: 1663_CR54
  publication-title: PSYCHIAT CLIN NEUROS
  doi: 10.1111/pcn.13561
– volume: 21
  start-page: e12910
  year: 2019
  ident: 1663_CR27
  publication-title: J Med Internet Res.
  doi: 10.2196/12910
– volume: 247
  start-page: 2543
  year: 1982
  ident: 1663_CR33
  publication-title: JAMA
  doi: 10.1001/jama.1982.03320430047030
– volume: 11
  start-page: 1100960
  year: 2023
  ident: 1663_CR2
  publication-title: China Front Public Health
  doi: 10.3389/fpubh.2023.1100960
– volume: 24
  start-page: 221
  year: 2016
  ident: 1663_CR62
  publication-title: AM J GERIAT PSYCHIAT
  doi: 10.1016/j.jagp.2015.12.005
– volume: 41
  start-page: 1182
  year: 2020
  ident: 1663_CR19
  publication-title: EUR HEART J
  doi: 10.1093/eurheartj/ehz849
– ident: 1663_CR41
  doi: 10.1016/B978-012369440-9/50024-4
– volume: 51
  start-page: 404
  year: 2019
  ident: 1663_CR17
  publication-title: Nat Genet
  doi: 10.1038/s41588-018-0311-9
– volume: 47
  start-page: 254
  year: 1996
  ident: 1663_CR52
  publication-title: Neurology
  doi: 10.1212/WNL.47.1.254
– volume: 64
  start-page: 1743
  year: 2007
  ident: 1663_CR53
  publication-title: Arch Neurol.
  doi: 10.1001/archneur.64.12.1743
– volume: 14
  start-page: 13747
  year: 2024
  ident: 1663_CR26
  publication-title: SCI REP-UK
  doi: 10.1038/s41598-024-64296-x
– volume: 8
  start-page: e12
  year: 2024
  ident: 1663_CR38
  publication-title: Health Lit Res Pract
– volume: 13
  year: 2024
  ident: 1663_CR40
  publication-title: Toxicol Rep
  doi: 10.1016/j.toxrep.2024.101756
– volume: 35
  start-page: 123
  year: 2022
  ident: 1663_CR10
  publication-title: Curr Opin Psychiatr
  doi: 10.1097/YCO.0000000000000768
– volume: 2022
  start-page: 6379141
  year: 2022
  ident: 1663_CR30
  publication-title: COMPUT INTEL NEUROSC
– volume: 86
  start-page: 1299
  year: 2015
  ident: 1663_CR49
  publication-title: J NEUROL NEUROSUR PS
– volume: 15
  start-page: 7
  year: 2023
  ident: 1663_CR55
  publication-title: ALZHEIMERS RES THER
  doi: 10.1186/s13195-022-01140-2
– volume: 4
  start-page: e84
  year: 2022
  ident: 1663_CR13
  publication-title: Lancet Digit Health
  doi: 10.1016/S2589-7500(21)00249-1
– volume: 21
  start-page: 271
  year: 2021
  ident: 1663_CR9
  publication-title: BMC Neurol.
  doi: 10.1186/s12883-021-02276-8
SSID ssj0066284
Score 2.3578577
Snippet Dementia is a major public health challenge in modern society. Early detection of high-risk dementia patients and timely intervention or treatment are of...
Background Dementia is a major public health challenge in modern society. Early detection of high-risk dementia patients and timely intervention or treatment...
Abstract Background Dementia is a major public health challenge in modern society. Early detection of high-risk dementia patients and timely intervention or...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 278
SubjectTerms Aged
Deep Learning
DeepSurv
Dementia
Dementia - epidemiology
Dementia - genetics
Environmental aspects
Female
Genetic aspects
Humans
Machine learning
Male
Middle Aged
Proportional Hazards Models
Prospective Studies
Risk Assessment - methods
Risk Factors
Risk prediction model
Survival Analysis
United Kingdom - epidemiology
Title Development of an individualized dementia risk prediction model using deep learning survival analysis incorporating genetic and environmental factors
URI https://www.ncbi.nlm.nih.gov/pubmed/39736679
https://www.proquest.com/docview/3150344213
https://pubmed.ncbi.nlm.nih.gov/PMC11684124
https://doaj.org/article/d767a1cd89324de5b1ea87220286f742
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF5BuXBBIF6GEhYJiQOy2vU-fWyjVhUSFUJUym213kfJxYmaRJX4H_xfZnadyBYHLhydHVuendeOM_MNIR_ByJKSmtWJeVkL7mPdStDlJL1nyQiePH7v-Hqtrm7El4VcjEZ9YU1YgQcuG3cStNKO-QBxtREhyo5FZ3QDObtRCfI69L4Q8_bJVPHBSoHX3bfIGHWyYZzlTmSsuIAYW99PwlBG6__bJ4-C0rRgchSBLp-SJ8PRkZ6VV35GHsT-Ofk9qvqhq0RdT5eHHqvlrxhoyB8Al45iFTld3-E_MygNmofgUCx8vwWiuKbDBIlbutmBAwEVhKcVyBKKGA4F8hjXQemw9xGWAx11ysENw_ieF-Tm8uLH_KoeRi3UXjKzrRNkXl50THXJdQyuWqMUxE8nQ6s6FlrnolSReYQLjIYLz12E04HXhiUVHH9JjvpVH18TKpUJruEpGBFESKFN2nkmpDl1zDnpKvJ5v_N2XRA1bM5EjLJFThbkZLOc7H1FzlE4B0pEw84_gI7YQUfsv3SkIu9RtLa0lh5s2p4ZYAFYZW1FPmUKtGqQsHdDcwKwhPhYE8rjCSVYo58sf9irj8UlLGHr42q3sRyO3lyIhvGKvCrqdOAKDoVcKQ13m4miTdiervTLnxkMnDFlcIL4m_-xUW_J4waNBIEsT4_J0fZuF9_BoWvbzchDvdAz8uj84vrbd7iaq_ks29wf4MExng
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Development+of+an+individualized+dementia+risk+prediction+model+using+deep+learning+survival+analysis+incorporating+genetic+and+environmental+factors&rft.jtitle=Alzheimer%27s+research+%26+therapy&rft.au=Yuan%2C+Shiqi&rft.au=Liu%2C+Qing&rft.au=Huang%2C+Xiaxuan&rft.au=Tan%2C+Shanyuan&rft.date=2024-12-30&rft.pub=BioMed+Central+Ltd&rft.issn=1758-9193&rft.eissn=1758-9193&rft.volume=16&rft.issue=1&rft_id=info:doi/10.1186%2Fs13195-024-01663-w&rft.externalDocID=A821889819
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1758-9193&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1758-9193&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1758-9193&client=summon